A Real Time cancer therapy guidance tool
Rna Diagnostics is dedicated to improving the management of cancer treatments.
The RNA Disruption Assay™ (RDA™) will provide physicians with an evaluation
of how patients are responding to cancer treatments. In real time.
If the cancer drugs
Total raised: $5M
Investors 4
| Date | Name | Website |
| - | Angel One ... | angelonene... |
| - | Golden Tri... | goldentria... |
| - | York Angel... | yorkangels... |
| - | Anges Québ... | angesquebe... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 08.11.2018 | Series A | $5M | iGan Partn... |